Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| PUMA BIOTECHNOLOGY, Inc. (NASDAQ: PBYI) | Delayed: 10.94 -0.32 (2.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.26 | 52 Week High | $82.81 | |||
| Open | $11.25 | 52 Week Low | $19.74 | |||
| Day High | $11.50 | P/E | N/A | |||
| Day Low | $10.91 | EPS | $-2.16 | |||
| Volume | 361,793 | |||||
